Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Muthiah Vaduganathan , Stefan Anker , Javed Butler , et al Added: 1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Dr Scott Isaacs, Prof Peter Rossing, Dr Muthiah Vaduganathan, Prof Stefan Anker and Dr Javed Butler discuss weight management for CRM disease. View more
Author(s): Gerasimos Filippatos , Gianluigi Savarese , , et al Added: 1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof Gerasimos Filippatos, Dr Manisha Sahay, Prof Gianluigi Savarese, Prof Francesco Cosentino and Prof Sam Seidu discuss multidisciplinary implementation strategies. View more
Author(s): Gianluigi Savarese , Antonio Ceriello , Shelley Zieroth , et al Added: 1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof Gianluigi Savarese, Dr Alice Cheng, Dr Adeera Levin, Prof Antonio Ceriello, Dr Shelley Zieroth and Prof Giuseppe Rosano discuss managing patients with CRM. View more
Author(s): John GF Cleland , Gerasimos Filippatos , Ewa Jankowska , et al Added: 1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof John Cleland, Prof Gerasimos Filippatos, Prof Ewa Jankowska, Prof David Wheeler, Dr Kieran Docherty discuss anaemia and iron deficiency. View more
Author(s): Ileana L Piña , Chiadi Ndumele , Mitja Lainscak , et al Added: 1 year ago
As part of e-SPACE Cardio-Renal-Metabolic 2024, Prof Ahmed Bennis, Dr Ileana L Pina, Dr Giulia Ferrannini, Dr Chiadi Ndumele, Prof Rodica Pop-Busui and Prof Mitja Lainscak discuss the epidemiology and pathophysiology of CRM disease. View more
Author(s): Andrew Wang Added: 8 months ago
AHA Scientific Sessions 2025 – MAPLE-HCM responder analysis shows aficamten monotherapy led to greater treatment effect when compared to metoprolol monotherapy.Dr Andrew Wang (Duke University Medical Center, Durham, NC, US) presents a responder analysis from the MAPLE-HCM trial (NCT05767346), examining clinical responses to aficamten monotherapy versus metoprolol in patients with obstructive… View more
Author(s): Gregory Lewis Added: 9 months ago
HFSA 25 - Aficamten improves excercise capacity compared to metoprolol in patients with obstructive hypertrophic cardiomyopathy in a prespecified analysis of the MAPLE-HCM study.Dr Gregory Lewis joins us to discuss findings from a prespecified cardiopulmonary exercise testing analysis of the MAPLE-HCM trial, which reveals divergent effects between aficamten and metoprolol on exercise performance… View more
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 1 year ago
Keep up to date with the top trials from AHA 24!CLEAR-SYNERGYSELECT-CABGSUMMITYELLOW IIIInternational Aortic Stenosis RegistryAMPLATZER IDEVALOR HCMWatch our full AHA 24 coverage in our Late-Breaking and Featured Science Collection. View more
Author(s): Tara Jones Added: 9 months ago
Learn about revascularisation strategies in cardiogenic shock after acute MI, including culprit-only vs multivessel PCI, from Dr Tara Jones (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick… View more
Author(s): Frederick Welt Added: 9 months ago
Learn about the definition and implications of a shock diagnosis and systems of care and the role of the shock team from Dr Frederick Welt (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick… View more